FRANCISCO CELIS: Open Payments
NPI 1518141233 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 27 payments from 8 companies in 2025. Trend: 2023 $910 · 2024 $825 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 17 | $189 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $60 |
| Journey Medical Corporation | 2 | $43 |
| Amgen Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Organon LLC | 1 | $5 |
Products named: OPZELURA, ILUMYA, OTEZLA, DUPIXENT, NEMLUVIO, SKYRIZI, VTAMA.
Industry payments across TX — which companies pay providers there.
